Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
662 | 12640 | 38.0 | 71% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1856 | 2383 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
2441 | 2174 | DYNORPHIN//CI 977//DYNORPHIN A |
4097 | 1771 | CHEM BIOL PEPTIDE//ENDOMORPHIN 2//ENDOMORPHIN |
6743 | 1374 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
7616 | 1268 | DELTA OPIOID RECEPTOR//DELTA OPIOID AGONIST//SNC80 |
9703 | 1063 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
10926 | 955 | MORPHINE WITHDRAWAL//EQUIP CELLULAR MOL PHARMACOL//ACUTE DEPENDENCE |
10947 | 953 | DRUG DISCRIMINATION//NOVEL RESPONSE PROCEDURE//TRAINING DOSE |
20230 | 407 | DUODENAL DISTENSION//KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL//EXPT CLIN PHYSIOPHARMACOL |
23401 | 292 | OHMEFENTANYL//FENTANYL ANALOGS//4 ANILIDOPIPERIDINES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOCICEPTIN | Author keyword | 1058 | 90% | 4% | 462 |
2 | ORPHANIN FQ | Author keyword | 954 | 98% | 2% | 244 |
3 | NOCICEPTIN ORPHANIN FQ | Author keyword | 627 | 94% | 2% | 222 |
4 | NOP RECEPTOR | Author keyword | 284 | 96% | 1% | 90 |
5 | SALVINORIN A | Author keyword | 229 | 91% | 1% | 94 |
6 | ORL1 RECEPTOR | Author keyword | 189 | 91% | 1% | 79 |
7 | CHEM BIOL PEPTIDE | Address | 162 | 80% | 1% | 99 |
8 | KAPPA OPIOID RECEPTOR | Author keyword | 161 | 50% | 2% | 234 |
9 | DELTA OPIOID RECEPTOR | Author keyword | 147 | 51% | 2% | 208 |
10 | MU OPIOID RECEPTOR | Author keyword | 143 | 35% | 3% | 338 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOCICEPTIN | 1058 | 90% | 4% | 462 | Search NOCICEPTIN | Search NOCICEPTIN |
2 | ORPHANIN FQ | 954 | 98% | 2% | 244 | Search ORPHANIN+FQ | Search ORPHANIN+FQ |
3 | NOCICEPTIN ORPHANIN FQ | 627 | 94% | 2% | 222 | Search NOCICEPTIN+ORPHANIN+FQ | Search NOCICEPTIN+ORPHANIN+FQ |
4 | NOP RECEPTOR | 284 | 96% | 1% | 90 | Search NOP+RECEPTOR | Search NOP+RECEPTOR |
5 | SALVINORIN A | 229 | 91% | 1% | 94 | Search SALVINORIN+A | Search SALVINORIN+A |
6 | ORL1 RECEPTOR | 189 | 91% | 1% | 79 | Search ORL1+RECEPTOR | Search ORL1+RECEPTOR |
7 | KAPPA OPIOID RECEPTOR | 161 | 50% | 2% | 234 | Search KAPPA+OPIOID+RECEPTOR | Search KAPPA+OPIOID+RECEPTOR |
8 | DELTA OPIOID RECEPTOR | 147 | 51% | 2% | 208 | Search DELTA+OPIOID+RECEPTOR | Search DELTA+OPIOID+RECEPTOR |
9 | MU OPIOID RECEPTOR | 143 | 35% | 3% | 338 | Search MU+OPIOID+RECEPTOR | Search MU+OPIOID+RECEPTOR |
10 | ORL1 | 141 | 93% | 0% | 53 | Search ORL1 | Search ORL1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ORPHANIN FQ | 1150 | 88% | 4% | 551 |
2 | ORL1 RECEPTOR | 983 | 93% | 3% | 377 |
3 | OPIATE RECEPTOR | 316 | 49% | 4% | 469 |
4 | ORPHANIN FQ NOCICEPTIN | 312 | 88% | 1% | 147 |
5 | FQ NOCICEPTIN | 279 | 97% | 1% | 83 |
6 | MESSAGE ADDRESS CONCEPT | 215 | 87% | 1% | 104 |
7 | NALTRINDOLE | 199 | 74% | 1% | 150 |
8 | ORL1 | 199 | 93% | 1% | 76 |
9 | BW373U86 | 144 | 94% | 0% | 50 |
10 | FQ | 142 | 79% | 1% | 92 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Challenges for opioid receptor nomenclature: IUPHAR Review 9 | 2015 | 17 | 44 | 50% |
Regulation of mu-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance | 2013 | 82 | 274 | 66% |
Heteromers of mu-delta opioid receptors: new pharmacology and novel therapeutic possibilities | 2015 | 7 | 80 | 66% |
Opioids and their receptors: Are we there yet? | 2014 | 14 | 64 | 92% |
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential | 2008 | 139 | 211 | 89% |
Opioid receptors | 2004 | 324 | 282 | 73% |
Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists | 2014 | 12 | 253 | 83% |
OPIOID-RECEPTOR MESSENGER-RNA EXPRESSION IN THE RAT CNS - ANATOMICAL AND FUNCTIONAL IMPLICATIONS | 1995 | 840 | 34 | 74% |
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse | 2010 | 128 | 165 | 65% |
Pharmacology of nociceptin and its receptor: a novel therapeutic target | 2000 | 268 | 196 | 98% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEM BIOL PEPTIDE | 162 | 80% | 0.8% | 99 |
2 | LCBRA | 65 | 90% | 0.2% | 28 |
3 | CLIN PSYCHOPHARMACOL SECT | 38 | 41% | 0.6% | 72 |
4 | BIOL ADDICT DIS | 36 | 33% | 0.7% | 90 |
5 | EQUIP CELLULAR MOL PHARMACOL | 30 | 100% | 0.1% | 12 |
6 | ANAESTHESIA CRIT CARE PAIN MANAGEMENT | 17 | 41% | 0.3% | 33 |
7 | FOOD MED SCI | 17 | 72% | 0.1% | 13 |
8 | UNITE NEUROPHARMACOL MOL | 15 | 88% | 0.1% | 7 |
9 | MED CHEM GRP | 14 | 29% | 0.3% | 41 |
10 | COTZIAS NEUROONCOL | 13 | 47% | 0.2% | 20 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000026969 | OPIOID GROWTH FACTOR//OPIOID GROWTH FACTOR RECEPTOR//BETA ENDORPHIN |
2 | 0.0000019735 | HYPERALGESIA//NEUROPATHIC PAIN//ANTINOCICEPTION |
3 | 0.0000012527 | RGS PROTEINS//G PROTEIN COUPLED RECEPTOR//RGS |
4 | 0.0000012412 | TRAMADOL//BREAKTHROUGH PAIN//MORPHINE 6 GLUCURONIDE |
5 | 0.0000012163 | SIGMA RECEPTOR//SIGMA1 RECEPTOR//SIGMA RECEPTORS |
6 | 0.0000011533 | NEUROTROPIN//TELE STEREO EEG//SART STRESS |
7 | 0.0000009735 | NUCLEUS ACCUMBENS//COCAINE//DOPAMINE |
8 | 0.0000008243 | UROTENSIN II//NEUROPEPTIDE FF//NEUROPEPTIDE S |
9 | 0.0000007938 | IBOGAINE//UNCARIA TOMENTOSA//YOKUKANSAN |
10 | 0.0000007903 | NEFOPAM//IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y |